Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

635
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
635
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Seizures: Classification01:13

Seizures: Classification

1.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

898
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
898
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

827
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
827

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency.

Nature biomedical engineering·2026
Same author

A disulfide-bridged single-stranded DNA nanotube for co-delivery of siRNA and chemotherapeutics in ovarian cancer therapy.

Frontiers in medicine·2026
Same author

Cytoplasmic RNase III Drosha controls lipogenesis by noncanonical regulation of SREBP1.

Molecular cell·2026
Same author

Nitrogen regulates starch biosynthesis and multiscale structural properties of Sorghum under low-light stress.

Food research international (Ottawa, Ont.)·2026
Same author

Correction to "Inhibitory Effects and Molecular Mechanisms of Selenium-Containing Tea Polysaccharides on Human Breast Cancer MCF-7 Cells".

Journal of agricultural and food chemistry·2026
Same author

Feasibility and acceptability of a remotely delivered, home-based "exercise snacking" to improve physical function in community-dwelling older adults: a 28-day pilot study.

Frontiers in medicine·2026

Related Experiment Video

Updated: Jan 16, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.9K

Graph based link prediction for epilepsy drug discovery.

Xiaolong Shi1, R Sundareswaran2, M Shanmugapriya3

  • 1Institute of Computing Science and Technology, Guangzhou University, Guangzhou, 510006, China.

Scientific Reports
|September 30, 2025
PubMed
Summary

This study introduces a computational framework using graph neural networks to predict phytochemical-protein interactions for novel epilepsy treatments. This approach offers a scalable, cost-effective alternative to traditional methods for developing natural epilepsy therapies.

Keywords:
Centrality measuresGraph attention networkGraph convolutional networkGraph neural networkGraph theoryGraphSAGE

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.4K

Related Experiment Videos

Last Updated: Jan 16, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.9K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.4K

Area of Science:

  • Computational Biology
  • Neuroscience
  • Pharmacology

Background:

  • Epilepsy affects millions globally, presenting significant social and neurological challenges.
  • Current understanding of epilepsy mechanisms is incomplete, hindering effective treatment development.
  • Phytochemical-protein interactions, inspired by Ayurveda, offer a promising avenue for epilepsy therapy, especially against drug-resistant cases.

Purpose of the Study:

  • To develop a computational framework for predicting phytochemical-protein interactions relevant to epilepsy treatment.
  • To leverage graph-based approaches and Graph Neural Networks (GNNs) for this prediction task.
  • To explore natural, Ayurveda-inspired alternatives for epilepsy management.

Main Methods:

  • Modeled phytochemical-protein interactions as a bipartite graph.
  • Employed Graph Convolutional Networks (GCN), Graph Attention Network (GAT), and GraphSAGE.
  • Utilized one-hop enclosing subgraphs to refine predictive performance.

Main Results:

  • The best-performing GNN model achieved high accuracy (0.9778), precision (0.9574), F1-score (0.9782), and ROC-AUC (0.9994).
  • Graph-based computational methods proved effective and scalable for predicting interactions.
  • The framework demonstrates potential for identifying novel epilepsy therapeutic candidates.

Conclusions:

  • The proposed computational framework accurately predicts phytochemical-protein interactions for potential epilepsy treatments.
  • Graph neural networks offer a powerful tool for drug discovery in neurological disorders.
  • Ayurveda-inspired phytochemicals show promise for natural epilepsy therapies, validated by computational modeling.